Exane Derivatives’s Columbus McKinnon CMCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,037
Closed -$44K 829
2022
Q1
$44K Sell
1,037
-428
-29% -$19.3K 0.01% 583
2021
Q4
$67.8K Buy
1,465
+184
+14% +$8.88K 0.02% 474
2021
Q3
$61.9K Hold
1,281
0.01% 598
2021
Q2
$59K Sell
1,281
-119
-9% -$6.1K 0.01% 629
2021
Q1
$73.9K Buy
1,400
+223
+19% +$10.6K 0.02% 467
2020
Q4
$45.2K Buy
1,177
+501
+74% +$18.8K 0.01% 464
2020
Q3
$22.4K Buy
+676
New +$23.5K 0.01% 433

Other funds holding CMCO

Exane Derivatives's CMCO Position: Q2 2022 in Review

Exane Derivatives sold out of Columbus McKinnon (CMCO) in Q2 2022, closing a stake of 1,037 shares — an estimated $44K sold.

Exane Derivatives first reported a position in CMCO in Q3 2020 and held it in 7 quarters. The position peaked at $73.9K in Q1 2021. 159 funds tracked by Wall St. Rank hold CMCO as of Q2 2022.

  • Exane Derivatives reported no remaining Columbus McKinnon position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 1,037 Columbus McKinnon shares in Q2 2022, an estimated $44K.
  • Exane Derivatives first reported a position in Columbus McKinnon in Q3 2020 and held it in 7 quarters.
  • Exane Derivatives's Columbus McKinnon position peaked at $73.9K in Q1 2021.
  • 159 funds tracked by Wall St. Rank held Columbus McKinnon as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.